{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:59:06Z","timestamp":1779256746139,"version":"3.51.4"},"publisher-location":"Cham","reference-count":118,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319442501","type":"print"},{"value":"9783319442518","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/5584_2016_149","type":"book-chapter","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T06:04:05Z","timestamp":1478239445000},"page":"167-180","source":"Crossref","is-referenced-by-count":28,"title":["Challenges in the Management of Hypertension in Older Populations"],"prefix":"10.1007","author":[{"given":"Lisa","family":"Pont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq","family":"Alhawassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"149_CR1","first-page":"2079","volume":"9","author":"TM Alhawassi","year":"2014","unstructured":"Alhawassi TM, Krass I, Bajorek BV, Pont LG (2014) A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging 9:2079\u20132086","journal-title":"Clin Interv Aging"},{"key":"149_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40545-015-0042-6","volume":"8","author":"TM Alhawassi","year":"2015","unstructured":"Alhawassi TM, Krass I, Pont LG (2015) Prevalence, prescribing and barriers to effective management of hypertension in older populations: a narrative review. J Pharm Policy Pract 8:24","journal-title":"J Pharm Policy Pract"},{"issue":"1","key":"149_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1161\/01.HYP.31.1.552","volume":"31","author":"WH Barker","year":"1998","unstructured":"Barker WH, Mullooly JP, Linton KL (1998) Trends in hypertension prevalence, treatment, and control in a well-defined older population. Hypertension 31(1):552\u2013559","journal-title":"Hypertension"},{"issue":"6","key":"149_CR4","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1590\/S0066-782X2001001200008","volume":"77","author":"SM Barreto","year":"2001","unstructured":"Barreto SM, Passos VMA, Firmo JOA, Guerra HL, Vidigal PG, Lima-Costa MFF (2001) Hypertension and clustering of cardiovascular risk factors in a community in Southeast Brazil: the Bambu\u00ed Health and Ageing Study. Arq Bras Cardiol 77(6):576\u2013581","journal-title":"Arq Bras Cardiol"},{"issue":"21","key":"149_CR5","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1001\/archinte.159.21.2553","volume":"159","author":"DW Bates","year":"1999","unstructured":"Bates DW, Miller EB, Cullen DJ, Burdick L, Williams L, Laird N et al (1999) Patient risk factors for adverse drug events in hospitalized patients. Arch Intern Med 159(21):2553\u20132560","journal-title":"Arch Intern Med"},{"issue":"9605","key":"149_CR6","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/S0140-6736(07)61700-0","volume":"370","author":"R Beaglehole","year":"2008","unstructured":"Beaglehole R, Ebrahim S, Reddy S, Vo\u00fbte J, Leeder S (2008) Prevention of chronic diseases: a call to action. Lancet 370(9605):2152\u20132157","journal-title":"Lancet"},{"key":"149_CR7","unstructured":"Beckett N, Peters R, Tuomilehto J, Swift C, Sever P, Potter J et al (2012) Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ 344"},{"issue":"5","key":"149_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1592\/phco.26.5.601","volume":"26","author":"C Bond","year":"2006","unstructured":"Bond C, Raehl CL (2006) Adverse drug reactions in United States hospitals. Pharmacotherapy 26(5):601\u2013608","journal-title":"Pharmacotherapy"},{"issue":"4","key":"149_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/jch.12281","volume":"16","author":"SG Bromfield","year":"2014","unstructured":"Bromfield SG, Bowling CB, Tanner RM, Peralta CA, Odden MC, Oparil S et al (2014) Trends in hypertension prevalence, awareness, treatment, and control among US adults 80 years and Older, 1988\u20132010. J Clin Hypertens 16(4):270\u2013276","journal-title":"J Clin Hypertens"},{"issue":"3","key":"149_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/jhh.2011.10","volume":"26","author":"C Bulpitt","year":"2011","unstructured":"Bulpitt C, Beckett N, Peters R, Leonetti G, Gergova V, Fagard R et al (2011) Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET). J Hum Hypertens 26(3):157\u2013163","journal-title":"J Hum Hypertens"},{"issue":"10","key":"149_CR11","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1007\/s00198-013-2369-7","volume":"24","author":"DA Butt","year":"2013","unstructured":"Butt DA, Mamdani M, Austin PC, Tu K, Gomes T, Glazier RH (2013) The risk of falls on initiation of antihypertensive drugs in the elderly. Osteoporos Int 24(10):2649\u20132657","journal-title":"Osteoporos Int"},{"issue":"8","key":"149_CR12","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1111\/jgs.12925","volume":"62","author":"ML Callisaya","year":"2014","unstructured":"Callisaya ML, Sharman JE, Close J, Lord SR, Srikanth VK (2014) Greater daily defined dose of antihypertensive medication increases the risk of falls in older people--a population-based study. J Am Geriatr Soc 62(8):1527\u20131533","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"149_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1161\/01.CIR.101.3.329","volume":"101","author":"OA Carretero","year":"2000","unstructured":"Carretero OA, Oparil S (2000) Essential hypertension part I: definition and etiology. Circulation 101(3):329\u2013335","journal-title":"Circulation"},{"issue":"19","key":"149_CR14","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289(19):2560\u20132571","journal-title":"JAMA"},{"issue":"22","key":"149_CR15","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1001\/jama.1985.03350460063022","volume":"253","author":"JD Curb","year":"1985","unstructured":"Curb JD, Borhani NO, Blaszkowski TP, Zimbaldi N, Fotiu S, Williams W (1985) Long-term surveillance for adverse effects of antihypertensive drugs. JAMA 253(22):3263\u20133268","journal-title":"JAMA"},{"issue":"7169","key":"149_CR16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/450494a","volume":"450","author":"AS Daar","year":"2007","unstructured":"Daar AS, Singer PA, Persad DL, Pramming SK, Matthews DR, Beaglehole R et al (2007) Grand challenges in chronic non-communicable diseases. Nature 450(7169):494\u2013496","journal-title":"Nature"},{"issue":"8778","key":"149_CR17","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/0140-6736(91)92589-T","volume":"338","author":"BHL Dahl\u00f6f","year":"1991","unstructured":"Dahl\u00f6f BHL, Lindholm L, Schersten B, Ekbom T, Wester P (1991) Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet 338(8778):1281\u20131285","journal-title":"Lancet"},{"issue":"5","key":"149_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cjca.2014.02.002","volume":"30","author":"K Dasgupta","year":"2014","unstructured":"Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS et al (2014) The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Canadian J Cardiol 30(5):485\u2013501","journal-title":"Canadian J Cardiol"},{"issue":"1","key":"149_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/157488607779315507","volume":"2","author":"EC Davies","year":"2007","unstructured":"Davies EC, Green CF, Mottram DR, Pirmohamed M (2007) Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2(1):79\u201387","journal-title":"Curr Drug Saf"},{"issue":"2","key":"149_CR20","doi-asserted-by":"publisher","first-page":"e4439","DOI":"10.1371\/journal.pone.0004439","volume":"4","author":"EC Davies","year":"2009","unstructured":"Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M (2009) Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One 4(2):e4439","journal-title":"PLoS One"},{"key":"149_CR21","unstructured":"Department of Economic and Social Affairs United Nations (2002) World population ageing: 1950\u20132050. UN"},{"issue":"4","key":"149_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/HCO.0b013e328338bcab","volume":"25","author":"G Devlin","year":"2010","unstructured":"Devlin G (2010) Women and elderly: subgroups under-represented in clinical trials. Curr Opin Cardiol 25(4):335\u2013339","journal-title":"Curr Opin Cardiol"},{"issue":"10","key":"149_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s40266-015-0296-3","volume":"32","author":"TS Dharmarajan","year":"2015","unstructured":"Dharmarajan TS, Dharmarajan L (2015) Tolerability of antihypertensive medications in older adults. Drugs Aging 32(10):773\u2013796","journal-title":"Drugs Aging"},{"issue":"9237","key":"149_CR24","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356(9237):1255\u20131259","journal-title":"Lancet"},{"issue":"1","key":"149_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1076-7460.2002.00856.x","volume":"11","author":"RH Fagard","year":"2002","unstructured":"Fagard RH (2002) Epidemiology of hypertension in the elderly. Am J Geriatr Cardiol 11(1):23\u201328","journal-title":"Am J Geriatr Cardiol"},{"issue":"9932","key":"149_CR26","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/S0140-6736(14)60688-7","volume":"383","author":"E Falaschetti","year":"2014","unstructured":"Falaschetti E, Mindell J, Knott C, Poulter N (2014) Hypertension management in England: a serial cross-sectional study from 1994 to 2011. Lancet 383(9932):1912\u20131919","journal-title":"Lancet"},{"issue":"8","key":"149_CR27","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/j.1532-5415.2004.52367.x","volume":"52","author":"TS Field","year":"2004","unstructured":"Field TS, Gurwitz JH, Harrold LR, Rothschild J, DeBellis KR, Seger AC et al (2004) Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 52(8):1349\u20131354","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"149_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000021995","volume":"44","author":"D Fliser","year":"1998","unstructured":"Fliser D, Ritz E (1998) Relationship between hypertension and renal function and its therapeutic implications in the elderly. Gerontology 44(3):123\u2013131","journal-title":"Gerontology"},{"issue":"1","key":"149_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/01.CIR.96.1.308","volume":"96","author":"SS Franklin","year":"1997","unstructured":"Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB et al (1997) Hemodynamic patterns of age-related changes in blood pressure The Framingham Heart Study. Circulation 96(1):308\u2013315","journal-title":"Circulation"},{"issue":"3","key":"149_CR30","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1161\/01.HYP.37.3.869","volume":"37","author":"SS Franklin","year":"2001","unstructured":"Franklin SS, Jacobs MJ, Wong ND, Gilbert J, Lapuerta P (2001) Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 37(3):869\u2013874","journal-title":"Hypertension"},{"issue":"21","key":"149_CR31","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1001\/archinte.158.21.2377","volume":"158","author":"G Gambassi","year":"1998","unstructured":"Gambassi G, Lapane K, Sgadari A, Landi F, Carbonin P, Hume A et al (1998) Prevalence, clinical correlates, and treatment of hypertension in elderly nursing home residents. Arch Intern Med 158(21):2377\u20132385","journal-title":"Arch Intern Med"},{"issue":"1","key":"149_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF01845916","volume":"4","author":"SR Gambert","year":"1994","unstructured":"Gambert SR (1994) Who are the \u201celderly\u201d? Geriatr Nephrol Urol 4(1):3\u20134","journal-title":"Geriatr Nephrol Urol"},{"key":"149_CR33","doi-asserted-by":"publisher","unstructured":"Gao Y, O\u2019Caoimh R, Healy L, Kerins DM, Eustace J, Guyatt G et al (2013) Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia. BMJ Open 3(7)","DOI":"10.1136\/bmjopen-2013-002881"},{"issue":"11","key":"149_CR34","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1001\/jama.2013.1954","volume":"309","author":"M Gheorghiade","year":"2013","unstructured":"Gheorghiade M, B\u00f6hm M, Greene SJ, Fonarow GC, Lewis EF, Zannad F et al (2013) Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. JAMA 309(11):1125\u20131135","journal-title":"JAMA"},{"key":"149_CR35","doi-asserted-by":"publisher","unstructured":"Gribbin J, Hubbard R, Gladman JR, Smith C, Lewis S (2010) Risk of falls associated with antihypertensive medication: population-based case\u2013control study. Age Ageing:afq092","DOI":"10.1093\/ageing\/afq092"},{"issue":"8","key":"149_CR36","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/pds.2176","volume":"20","author":"J Gribbin","year":"2011","unstructured":"Gribbin J, Hubbard R, Gladman J, Smith C, Lewis S (2011) Risk of falls associated with antihypertensive medication: self-controlled case series. Pharmacoepidemiol Drug Saf 20(8):879\u2013884","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8883","key":"149_CR37","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/0140-6736(93)92244-N","volume":"342","author":"JM Grimshaw","year":"1993","unstructured":"Grimshaw JM, Russell IT (1993) Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342(8883):1317\u20131322","journal-title":"Lancet"},{"issue":"1","key":"149_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/0003-4819-137-1-200207020-00007","volume":"137","author":"CP Gross","year":"2002","unstructured":"Gross CP, Mallory R, Heiat A, Krumholz HM (2002) Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med 137(1):10\u201316","journal-title":"Ann Intern Med"},{"issue":"1","key":"149_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pcad.2006.06.002","volume":"49","author":"E Grossman","year":"2006","unstructured":"Grossman E, Messerli FH (2006) Long-term safety of antihypertensive therapy. Prog Cardiovasc Dis 49(1):16\u201325","journal-title":"Prog Cardiovasc Dis"},{"issue":"12","key":"149_CR40","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1291\/hypres.31.2115","volume":"31","author":"JS Group","year":"2008","unstructured":"Group JS (2008) Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 31(12):2115\u20132127","journal-title":"Hypertens Res"},{"issue":"2","key":"149_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/jama.290.2.199","volume":"290","author":"I Hajjar","year":"2003","unstructured":"Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988\u20132000. JAMA 290(2):199\u2013206","journal-title":"JAMA"},{"key":"149_CR42","unstructured":"Halter JB (2009) Hazzard\u2019s geriatric medicine and gerontology. McGraw-Hill Companies"},{"issue":"9192","key":"149_CR43","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/S0140-6736(99)10327-1","volume":"354","author":"LLL Hansson","year":"1999","unstructured":"Hansson LLL, Ekbom T, Dahl\u00f6f B, Lanke J, Scherst\u00e9n B et al (1999) Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 354(9192):1751\u20131756","journal-title":"Lancet"},{"issue":"15","key":"149_CR44","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1001\/archinte.162.15.1682","volume":"162","author":"A Heiat","year":"2002","unstructured":"Heiat A, Gross CP, Krumholz HM (2002) Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 162(15):1682\u20131688","journal-title":"Arch Intern Med"},{"issue":"3","key":"149_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/ciia.2006.1.3.289","volume":"1","author":"AD Huebschmann","year":"2006","unstructured":"Huebschmann AD, Bublitz C, Anderson RJ (2006) Are hypertensive elderly patients treated differently? Clin Interven Aging 1(3):289","journal-title":"Clin Interven Aging"},{"issue":"5","key":"149_CR46","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311(5):507\u2013520","journal-title":"JAMA"},{"key":"149_CR47","unstructured":"Jaques H, National Institute for H, Clinical E (2013) NICE guideline on hypertension. Eur Heart J 34(6):406\u2013408"},{"issue":"6","key":"149_CR48","first-page":"573","volume":"54","author":"WB Kannel","year":"1978","unstructured":"Kannel WB, Gordan T (1978) Evaluation of cardiovascular risk in the elderly: the Framingham study. Bull N Y Acad Med 54(6):573\u2013591","journal-title":"Bull N Y Acad Med"},{"issue":"6809","key":"149_CR49","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35041682","volume":"408","author":"TB Kirkwood","year":"2000","unstructured":"Kirkwood TB, Austad SN (2000) Why do we age? Nature 408(6809):233\u2013238","journal-title":"Nature"},{"issue":"6","key":"149_CR50","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jash.2013.05.006","volume":"7","author":"M Kleman","year":"2013","unstructured":"Kleman M, Dhanyamraju S, DiFilippo W (2013) Prevalence and characteristics of pseudohypertension in patients with \u201cresistant hypertension\u201d. J Am Soc Hypertens 7(6):467\u2013470","journal-title":"J Am Soc Hypertens"},{"issue":"2","key":"149_CR51","first-page":"56","volume":"2","author":"J Kumar","year":"2013","unstructured":"Kumar J (2013) Epidemiology of hypertension. Clinical Queries. Nephrology 2(2):56\u201361","journal-title":"Nephrology"},{"issue":"5","key":"149_CR52","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.cjca.2014.02.012","volume":"30","author":"P Larochelle","year":"2014","unstructured":"Larochelle P, Tobe SW, Lacourci\u00e8re Y (2014) \u03b2-blockers in hypertension: studies and meta-analyses over the years. Can J Cardiol 30(5):S16\u2013S22","journal-title":"Can J Cardiol"},{"issue":"15","key":"149_CR53","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279(15):1200\u20131205","journal-title":"JAMA"},{"issue":"3","key":"149_CR54","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/eb-2014-101987","volume":"18","author":"DS Lee","year":"2015","unstructured":"Lee DS, Goeres LM (2015) Higher antihypertensive dose increases risk of falls in older people. Evid Based Nurs 18(3):96","journal-title":"Evid Based Nurs"},{"issue":"9859","key":"149_CR55","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","volume":"380","author":"SS Lim","year":"2013","unstructured":"Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H et al (2013) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2224\u20132260","journal-title":"Lancet"},{"issue":"4","key":"149_CR56","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/jama.294.4.466","volume":"294","author":"DM Lloyd-Jones","year":"2005","unstructured":"Lloyd-Jones DM, Evans JC, Levy D (2005) Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 294(4):466\u2013472","journal-title":"JAMA"},{"key":"149_CR57","unstructured":"Luehr DWT, Burke R, Dohmen F, Hayes R, Johnson M, Kerandi H, Margolis K, Marshall M, O\u2019Connor P, Pereira C, Reddy G, Schlichte A, Schoenleber M (2012) Hypertension diagnosis and treatment. Institute for Clinical Systems Improvement [Internet]. Updated November 2012. Available from: http:\/\/bit.ly\/Hypertension1112"},{"issue":"1","key":"149_CR58","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0895-7061(01)02228-2","volume":"15","author":"RH Mackey","year":"2002","unstructured":"Mackey RH, Sutton-Tyrrell K, Vaitkevicius PV, Sakkinen PA, Lyles MF, Spurgeon HA et al (2002) Correlates of aortic stiffness in elderly individuals: a subgroup of the Cardiovascular Health Study. Am J Hypertens 15(1):16\u201323","journal-title":"Am J Hypertens"},{"issue":"9132","key":"149_CR59","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S0140-6736(97)11390-3","volume":"352","author":"M Maclure","year":"1998","unstructured":"Maclure M, Dormuth C, Naumann T, McCormack J, Rangno R, Whiteside C et al (1998) Influences of educational interventions and adverse news about calcium-channel blockers on first-line prescribing of antihypertensive drugs to elderly people in British Columbia. Lancet 352(9132):943\u2013948","journal-title":"Lancet"},{"issue":"1","key":"149_CR60","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00004872-198402000-00015","volume":"2","author":"SW MacMahon","year":"1984","unstructured":"MacMahon SW, Blacket RB, Macdonald GJ, Hall W (1984) Obesity, alcohol consumption and blood pressure in Australian men and women the National Heart Foundation of Australia Risk Factor Prevalence Study. J Hypertens 2(1):85\u201391","journal-title":"J Hypertens"},{"issue":"28","key":"149_CR61","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, B\u00f6hm M et al (2013) 2013 ESH\/ESC Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34(28):2159\u20132219","journal-title":"Eur Heart J"},{"issue":"10","key":"149_CR62","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1001\/archinte.1992.00400220015004","volume":"152","author":"SJ Mann","year":"1992","unstructured":"Mann SJ (1992) Systolic hypertension in the elderly: pathophysiology and management. Arch Intern Med 152(10):1977\u20131984","journal-title":"Arch Intern Med"},{"key":"149_CR63","unstructured":"Masoro EJ, Austad SN (2006) Handbook of the biology of aging. Academic press"},{"issue":"11","key":"149_CR64","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3(11):e442","journal-title":"PLoS Med"},{"issue":"9","key":"149_CR65","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1097\/00004872-200409000-00011","volume":"22","author":"A Menotti","year":"2004","unstructured":"Menotti A, Lanti M, Kafatos A, Nissinen A, Dontas A, Nedeljkovic S et al (2004) The role of a baseline casual blood pressure measurement and of blood pressure changes in middle age in prediction of cardiovascular and all-cause mortality occurring late in life: a cross-cultural comparison among the European cohorts of the Seven Countries Study. J Hypertens 22(9):1683\u20131690","journal-title":"J Hypertens"},{"issue":"6","key":"149_CR66","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1161\/01.HYP.0000128420.01881.aa","volume":"43","author":"GF Mitchell","year":"2004","unstructured":"Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA et al (2004) Changes in arterial stiffness and wave reflection with advancing age in healthy men and women the Framingham Heart Study. Hypertension 43(6):1239\u20131245","journal-title":"Hypertension"},{"issue":"7","key":"149_CR67","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0895-7061(97)00056-3","volume":"10","author":"M Monane","year":"1997","unstructured":"Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J (1997) The effects of initial drug choice and comorbidity on antihypertensive therapy compliance* results from a population-based study in the elderly. Am J Hypertens 10(7):697\u2013704","journal-title":"Am J Hypertens"},{"issue":"3","key":"149_CR68","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1046\/j.1365-2125.1998.00667.x","volume":"45","author":"N Moore","year":"1998","unstructured":"Moore N, Lecointre D, Noblet C, Mabille M (1998) Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 45(3):301\u2013308","journal-title":"Br J Clin Pharmacol"},{"issue":"22","key":"149_CR69","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1001\/jama.279.22.1813","volume":"279","author":"M Moser","year":"1998","unstructured":"Moser M (1998) Why are physicians not prescribing diuretics more frequently in the management of hypertension? JAMA 279(22):1813\u20131816","journal-title":"JAMA"},{"issue":"9064","key":"149_CR70","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","volume":"349","author":"CJ Murray","year":"1997","unstructured":"Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990\u20132020: Global Burden of Disease Study. Lancet 349(9064):1498\u20131504","journal-title":"Lancet"},{"key":"149_CR71","doi-asserted-by":"publisher","unstructured":"Musini VM, Tejani AM, Bassett K, Wright JM (2009) Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2009(4):CD000028","DOI":"10.1002\/14651858.CD000028.pub2"},{"key":"149_CR72","unstructured":"National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee) (2010) Guide to management of hypertension 2008. Updated December 2010. Accessed via https:\/\/heartfoundation.org.au\/images\/uploads\/publications\/HypertensionGuidelines2008to2010Update.pdf on April 15, 2016"},{"key":"149_CR73","unstructured":"Officers A, Coordinators for the ACRGTA, Lipid-Lowering Treatment to Prevent Heart Attack T (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288(23):2981\u20132997"},{"issue":"2","key":"149_CR74","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/HYPERTENSIONAHA.109.146035","volume":"56","author":"T Ogihara","year":"2010","unstructured":"Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K et al (2010) Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension 56(2):196\u2013202","journal-title":"Hypertension"},{"issue":"2","key":"149_CR75","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/080370599438266","volume":"8","author":"H Olsen","year":"1999","unstructured":"Olsen H, Klemetsrud T, Stokke HP, Tretli S, Westheim A (1999) Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway. Blood Press 8(2):94\u2013101","journal-title":"Blood Press"},{"issue":"5","key":"149_CR76","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/sj.jhh.1001176","volume":"15","author":"G Onder","year":"2001","unstructured":"Onder G, Gambassi G, Landi F, Pedone C, Cesari M, Carbonin P et al (2001) Trends in antihypertensive drugs in the elderly: the decline of thiazides. J Hum Hypertens 15(5):291\u2013297","journal-title":"J Hum Hypertens"},{"issue":"12","key":"149_CR77","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1046\/j.1532-5415.2002.50607.x","volume":"50","author":"G Onder","year":"2002","unstructured":"Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R et al (2002) Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 50(12):1962\u20131968","journal-title":"J Am Geriatr Soc"},{"issue":"9008","key":"149_CR78","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S0140-6736(96)90276-7","volume":"347","author":"M Pahor","year":"1996","unstructured":"Pahor M, Carbonin P, Guralnik J, Havlik R, Furberg C (1996a) Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 347(9008):1061\u20131065","journal-title":"Lancet"},{"issue":"9026","key":"149_CR79","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0140-6736(96)04277-8","volume":"348","author":"M Pahor","year":"1996","unstructured":"Pahor M, Guralnik JM, Ferrucci L, Corti M-C, Salive ME, Cerhan JR et al (1996b) Calcium-channel blockade and incidence of cancer in aged populations. Lancet 348(9026):493\u2013497","journal-title":"Lancet"},{"issue":"23","key":"149_CR80","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","volume":"367","author":"H-H Parving","year":"2012","unstructured":"Parving H-H, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD et al (2012) Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 367(23):2204\u20132213","journal-title":"N Engl J Med"},{"issue":"1","key":"149_CR81","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/01.STR.20.1.4","volume":"20","author":"HM Perry Jr","year":"1989","unstructured":"Perry HM Jr, Smith WM, McDonald RH, Black D, Cutler JA, Furberg CD et al (1989) Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. Stroke 20(1):4\u201313","journal-title":"Stroke"},{"issue":"5","key":"149_CR82","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nrcardio.2012.27","volume":"9","author":"E Pimenta","year":"2012","unstructured":"Pimenta E, Oparil S (2012) Management of hypertension in the elderly. Nat Rev Cardiol 9(5):286\u2013296","journal-title":"Nat Rev Cardiol"},{"issue":"976","key":"149_CR83","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/pgmj.2006.048371","volume":"83","author":"E Pinto","year":"2007","unstructured":"Pinto E (2007) Blood pressure and ageing. Postgrad Med J 83(976):109\u2013114","journal-title":"Postgrad Med J"},{"issue":"7456","key":"149_CR84","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ et al (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329(7456):15\u201319","journal-title":"BMJ"},{"issue":"12","key":"149_CR85","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/sj.jhh.1001117","volume":"14","author":"M Prencipe","year":"2000","unstructured":"Prencipe M, Casini A, Santini M, Ferretti C, Scaldaferri N, Culasso F (2000) Prevalence, awareness, treatment and control of hypertension in the elderly: results from a population survey. J Hum Hypertens 14(12):825\u2013830","journal-title":"J Hum Hypertens"},{"issue":"6","key":"149_CR86","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1097\/00004872-200406000-00008","volume":"22","author":"P Primatesta","year":"2004","unstructured":"Primatesta P, Poulter NR (2004) Hypertension management and control among English adults aged 65 years and older in 2000 and 2001. J Hypertens 22(6):1093\u20131098","journal-title":"J Hypertens"},{"issue":"1","key":"149_CR87","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/HJH.0b013e32834d9eda","volume":"30","author":"MJ Prince","year":"2012","unstructured":"Prince MJ, Ebrahim S, Acosta D, Ferri CP, Guerra M, Huang Y et al (2012) Hypertension prevalence, awareness, treatment and control among older people in Latin America, India and China: a 10\/66 cross-sectional population-based survey. J Hypertens 30(1):177\u2013187","journal-title":"J Hypertens"},{"issue":"18","key":"149_CR88","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1001\/jama.1995.03520420052037","volume":"273","author":"BM Psaty","year":"1995","unstructured":"Psaty BM, Koepsell TD, Yanez ND, Smith NL, Manolio TA, Heckbert SR et al (1995) Temporal patterns of antihypertensive medication use among older adults, 1989 through 1992: an effect of the major clinical trials on clinical practice? JAMA 273(18):1436\u20131438","journal-title":"JAMA"},{"issue":"20","key":"149_CR89","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1001\/archinte.162.20.2325","volume":"162","author":"BM Psaty","year":"2002","unstructured":"Psaty BM, Manolio TA, Smith NL, Heckbert SR, Gottdiener JS, Burke GL et al (2002) Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study. Arch Intern Med 162(20):2325\u20132332","journal-title":"Arch Intern Med"},{"key":"149_CR90","unstructured":"Rai GS, Mulley GP (2007) Elderly medicine: a training guide. Elsevier Health Sciences"},{"issue":"4","key":"149_CR91","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrendo.2013.20","volume":"9","author":"L Rejnmark","year":"2013","unstructured":"Rejnmark L (2013) The ageing endocrine system: fracture risk after initiation of antihypertensive therapy. Nat Rev Endocrinol 9(4):189\u2013190","journal-title":"Nat Rev Endocrinol"},{"issue":"Suppl1","key":"149_CR92","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.4103\/0976-500X.120954","volume":"4","author":"P Rende","year":"2013","unstructured":"Rende P, Paletta L, Gallelli G, Raffaele G, Natale V, Brissa N et al (2013) Retrospective evaluation of adverse drug reactions induced by antihypertensive treatment. J Pharmacol Pharmacotherap 4(Suppl1):S47","journal-title":"J Pharmacol Pharmacotherap"},{"issue":"2","key":"149_CR93","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/hr.2013.130","volume":"37","author":"GC Rodriguez-Roca","year":"2013","unstructured":"Rodriguez-Roca GC, Llisterri JL, Prieto-Diaz MA, Alonso-Moreno FJ, Escobar-Cervantes C, Pallares-Carratala V et al (2013) Blood pressure control and management of very elderly patients with hypertension in primary care settings in Spain. Hypertens Res 37(2):166\u2013171","journal-title":"Hypertens Res"},{"issue":"2","key":"149_CR94","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40263-015-0230-6","volume":"29","author":"L Rouch","year":"2015","unstructured":"Rouch L, Cestac P, Hanon O, Cool C, Helmer C, Bouhanick B et al (2015) Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms. CNS Drugs 29(2):113\u2013130","journal-title":"CNS Drugs"},{"key":"149_CR95","first-page":"143","volume":"5","author":"I Sato","year":"2013","unstructured":"Sato I, Akazawa M (2013) Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study. Drug Healthcare Patient Saf 5:143\u2013150","journal-title":"Drug Healthcare Patient Saf"},{"key":"149_CR96","doi-asserted-by":"crossref","unstructured":"Sch\u00e4fer H-H, De Villiers JN, Sudano I, Dischinger S, Theus G-R, Zilla P et al (2012) Recommendations for the treatment of hypertension in the elderly and very elderly\u2013a scotoma within international guidelines. Swiss Med Wkly Epub","DOI":"10.4414\/smw.2012.13574"},{"issue":"4","key":"149_CR97","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/hr.2014.20","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M et al (2014) The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 37(4):253\u2013387","journal-title":"Hypertens Res"},{"issue":"1","key":"149_CR98","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.amjmed.2004.01.024","volume":"117","author":"CB Spranger","year":"2004","unstructured":"Spranger CB, Ries AJ, Berge CA, Radford NB, Victor RG (2004) Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med 117(1):14\u201318","journal-title":"Am J Med"},{"issue":"5","key":"149_CR99","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11906-006-0086-8","volume":"8","author":"S Stas","year":"2006","unstructured":"Stas S, Appesh L, Sowers J (2006) Metabolic safety of antihypertensive drugs: myth versus reality. Current Hypertens Rep 8(5):403\u2013408","journal-title":"Current Hypertens Rep"},{"issue":"6","key":"149_CR100","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0895-7061(96)00026-X","volume":"9","author":"LP Svetkey","year":"1996","unstructured":"Svetkey LP, George LK, Tyroler HA, Timmons PZ, Burchett BM, Blazer DG (1996) Effects of gender and ethnic group on blood pressure control in the elderly. Am J Hypertens 9(6):529\u2013535","journal-title":"Am J Hypertens"},{"key":"149_CR101","volume-title":"Stephens\u2019 detection of new adverse drug reactions","author":"J Talbot","year":"2004","unstructured":"Talbot J, Waller P (2004) Stephens\u2019 detection of new adverse drug reactions. Wiley, New York"},{"key":"149_CR102","unstructured":"The World Health Organisation (2016) Projections of mortality and causes of death, 2015 and 2030. Accessed via http:\/\/www.who.int\/healthinfo\/global_burden_disease\/projections\/en\/on 15 April 2016"},{"issue":"17","key":"149_CR103","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1001\/jama.1995.03520410042024","volume":"273","author":"ME Tinetti","year":"1995","unstructured":"Tinetti ME, Inouye SK, Gill TM, Doucette JT (1995) Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA 273(17):1348\u20131353","journal-title":"JAMA"},{"issue":"4","key":"149_CR104","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamainternmed.2013.14764","volume":"174","author":"ME Tinetti","year":"2014","unstructured":"Tinetti ME, Han L, Lee DS, McAvay GJ, Peduzzi P, Gross CP et al (2014) Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med 174(4):588\u2013595","journal-title":"JAMA Intern Med"},{"issue":"6","key":"149_CR105","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/00004872-199406000-00012","volume":"12","author":"P Trenkwalder","year":"1994","unstructured":"Trenkwalder P, Ruland D, Stender M, Gebhard J, Trenkwalder C, Lydtin H et al (1994) Prevalence, awareness, treatment and control of hypertension in a population over the age of 65 years: results from the Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly (STEPHY). J Hypertens 12(6):709","journal-title":"J Hypertens"},{"issue":"2","key":"149_CR106","first-page":"1225","volume":"10","author":"A Triantafyllou","year":"2010","unstructured":"Triantafyllou A, Douma S, Petidis K, Doumas M, Panagopoulou E, Pyrpasopoulou A et al (2010) Prevalence, awareness, treatment and control of hypertension in an elderly population in Greece. Rural Remote Health 10(2):1225","journal-title":"Rural Remote Health"},{"issue":"2","key":"149_CR107","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.amjopharm.2006.06.004","volume":"4","author":"K Tu","year":"2006","unstructured":"Tu K, Campbell NR, Chen Z, McAlister FA (2006) Thiazide diuretics for hypertension: prescribing practices and predictors of use in 194,761 elderly patients with hypertension. Am J Geriatr Pharmacother 4(2):161\u2013167","journal-title":"Am J Geriatr Pharmacother"},{"issue":"7653","key":"149_CR108","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1136\/bmj.39548.738368.BE","volume":"336","author":"F Turnbull","year":"2008","unstructured":"Turnbull F, Neal B, Ninomiya T, Algert C, Arima H, Barzi F et al (2008) Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 336(7653):1121\u20131123","journal-title":"BMJ"},{"issue":"4","key":"149_CR109","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s002280050467","volume":"54","author":"D Kraaij Van","year":"1998","unstructured":"Van Kraaij D, Jansen R, Gribnau F, Hoefnagels W (1998) Loop diuretics in patients aged 75 years or older: general practitioners\u2019 assessment of indications and possibilities for withdrawal. Eur J Clin Pharmacol 54(4):323\u2013327","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"149_CR110","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jama.287.8.1003","volume":"287","author":"RS Vasan","year":"2002","unstructured":"Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D\u2019Agostino RB et al (2002) Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 287(8):1003\u20131010","journal-title":"JAMA"},{"issue":"1","key":"149_CR111","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1161\/HYPERTENSIONAHA.107.089391","volume":"50","author":"SM Wallace","year":"2007","unstructured":"Wallace SM, McEniery CM, M\u00e4ki-Pet\u00e4j\u00e4 KM, Booth AD, Cockcroft JR, Wilkinson IB (2007) Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension 50(1):228\u2013233","journal-title":"Hypertension"},{"issue":"1","key":"149_CR112","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/HJH.0000000000000065","volume":"32","author":"MA Weber","year":"2014","unstructured":"Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG et al (2014) Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens 32(1):3\u201315","journal-title":"J Hypertens"},{"issue":"3","key":"149_CR113","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1161\/01.HYP.27.3.481","volume":"27","author":"MH Weinberger","year":"1996","unstructured":"Weinberger MH (1996) Salt sensitivity of blood pressure in humans. Hypertension 27(3):481\u2013490","journal-title":"Hypertension"},{"issue":"4","key":"149_CR114","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1365-2125.2007.03064.x","volume":"65","author":"K Wester","year":"2008","unstructured":"Wester K, Jonsson AK, Spigset O, Druid H, Hagg S (2008) Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 65(4):573\u2013579","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"149_CR115","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1365-2044.2010.06456.x","volume":"65","author":"SM White","year":"2010","unstructured":"White SM (2010) Including the very elderly in clinical trials. Anaesthesia 65(8):778\u2013780","journal-title":"Anaesthesia"},{"issue":"5","key":"149_CR116","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2165\/00019053-199915050-00003","volume":"15","author":"TJ White","year":"1999","unstructured":"White TJ, Arakelian A, Rho JP (1999) Counting the costs of drug-related adverse events. Pharmacoeconomics 15(5):445\u2013458","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"149_CR117","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMoa021716","volume":"348","author":"LM Wing","year":"2003","unstructured":"Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL et al (2003) A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 348(7):583\u2013592","journal-title":"N Engl J Med"},{"issue":"9650","key":"149_CR118","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/S0140-6736(08)61366-5","volume":"372","author":"G Yang","year":"2008","unstructured":"Yang G, Kong L, Zhao W, Wan X, Zhai Y, Chen LC et al (2008) Emergence of chronic non-communicable diseases in China. Lancet 372(9650):1697\u20131705","journal-title":"Lancet"}],"container-title":["Advances in Experimental Medicine and Biology","Hypertension: from basic research to clinical practice"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2016_149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T06:31:54Z","timestamp":1657607514000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/5584_2016_149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319442501","9783319442518"],"references-count":118,"URL":"https:\/\/doi.org\/10.1007\/5584_2016_149","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}